Clinical trial Recruiting at 1 site Interventional Ages 18 and up

A study using wearable devices to manage Long COVID symptoms

Official title: The Long COVID-19 Wearable Device Study

Run by Scripps Translational Science Institute · NCT05741112 · Data updated 2026-11-12

This study is testing if using wearable devices can help people with Long COVID manage their symptoms and improve their quality of life.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100500 (estimated)
SponsorScripps Translational Science Institute
Academic / other
Locations1 site (La Jolla, California)
StatusRecruiting
StartedNovember 16, 2023
Main results expectedDecember 1, 2025
Study endsDecember 1, 2025
Registry record updatedMay 11, 2025
Trial IDNCT05741112 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults diagnosed with Long COVID, ME/CFS, or POTS who are interested in using wearable technology for symptom management.

Probably not a fit

Patients without a diagnosis of Long COVID, ME/CFS, or POTS, or those not interested in using wearable devices may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to better understand Long COVID by collecting data from individuals who either own wearable devices or are provided with one. Participants will be randomized into two groups: one will share data from their existing devices while receiving educational materials, and the other will receive a wearable device along with pacing education. The goal is to analyze the data and survey responses to improve symptom management and quality of life for those affected by Long COVID and related conditions. The study will include up to 100,000 participants, with a focus on post-exertional malaise.

Why it matters

Potential benefit: If successful, this study could provide valuable insights and tools for managing Long COVID symptoms, potentially improving patients' quality of life.

How similar studies have gone: Other studies utilizing wearable devices for chronic condition management have shown promise, suggesting this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Is at least 18 years old.
* Has a self/and or physician diagnosis of:
* Long COVID (based on the WHO working definition),
* ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or
* POTS (Postural Orthostatic Tachycardia Syndrome).
* Is interested in tools to manage ME/CFS, POTS, and/or Long COVID symptoms.
* Owns a wearable device they are willing to use for this study or does not own a device and agrees to utilize a study-provided one.
* Agrees to wear the device throughout the study period, share the data with the study, and sync data at least weekly.
* Has access to a smartphone or tablet to enable syncing wearable data and viewing device feedback.
* Agrees to disclose involvement in other ME/CFS, POTS, and/or Long COVID interventions such as medical treatment, self-management, and other interventional studies.
* Agrees to complete at least 75% of the study surveys.

Exclusion Criteria:

* As long as they meet inclusion there is no exclusion

Where it's running

  • Scripps Research
    La Jolla, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.